{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:49:05Z","timestamp":1783194545115,"version":"3.54.6"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Type 2 diabetic osteoporosis (T2DOP) has received considerable attention due to its accelerated bone deterioration and significantly increased fracture risk. Unlike classical osteoporosis, patients with T2DOP often exhibit a paradoxical pattern: they have normal or even elevated bone mineral density (BMD) in early stages despite deterioration in bone microarchitecture. This paradox highlights the clinical importance of identifying T2DOP as a distinct and critical subtype of secondary osteoporosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a bibliometric analysis of literature on T2DOP published over the past 20 Years(from 2001 to 2020), using data retrieved from the Web of Science Core Collection database. Bibliometric networks were visualized and analyzed using VOSviewer. Publication trends, geographic contributions, research hotspots, and keyword clusters were systematically examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Over the past 20 Years, global research output on T2DOP steadily increased, with major contributions from North America, East Asia, and Western Europe. Identified research hotspots included risk prediction, biomarkers (e.g., advanced glycation end-products), complication management, population-specific characteristics (e.g., postmenopausal women), and therapeutic strategies (e.g., metformin). Notably, lifestyle intervention has recently emerged as an important new research direction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study provides the first comprehensive bibliometric analysis and visualization of global research trends and hotspots in T2DOP, highlighting critical insights for clinical practice, including the identification of at-risk populations, biomarker-guided risk assessment, and therapeutic optimization, which complements existing clinical meta-analyses. Future research efforts should emphasize multidisciplinary collaboration and validation of the long-term efficacy of lifestyle interventions. For clinical practice, integrating bone density evaluation with biomarker screening (e.g., osteocalcin) in diabetic patients could enhance early fracture prevention. Public health initiatives should prioritize lifestyle interventions in high-risk populations (e.g., postmenopausal women) to mitigate the growing burden of diabetic osteoporosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcdhc.2025.1596938","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:34Z","timestamp":1749528634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The status and trends of type 2 diabetic osteoporosis research: a global bibliometric and visualization analysis over the past 20 years"],"prefix":"10.3389","volume":"6","author":[{"given":"Haiyan","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","volume-title":"IDF Diabetes Atlas","author":"Magliano","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"Jama J Am. Med. Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00283-1","article-title":"Type 2 diabetes and the skeleton: new insights into sweet bones","volume":"4","author":"Shanbhogue","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ptr\/kpg038","article-title":"Bibliometric analysis of psychotherapy research: performance assessment and position in the journal landscape","volume":"13","author":"van Raan","year":"2003","journal-title":"Psychother. Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.wneu.2014.12.003","article-title":"Letter to the editor regarding analysis of changing paradigms of management in 179 patients with spinal tuberculosis during a 12-year period and proposal of a new management algorithm","volume":"84","author":"Ekinci","year":"2015","journal-title":"World Neurosurg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/0028-3886.253969","article-title":"Bibliometric analysis of the top-cited articles on idiopathic intracranial hypertension","volume":"67","author":"Samanci","year":"2019","journal-title":"Neurol. India"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e31825902ce","article-title":"Genetic variation in GSTM1 is associated with susceptibility to noise-induced hearing loss in a Chinese population","volume":"54","author":"Shen","year":"2012","journal-title":"J. Occup. Environ. Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17223","article-title":"Global scientific trends on exosome research during 2007-2016: a bibliometric analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de L","year":"2005","journal-title":"Osteoporos Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am. J. Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-016-3146-y","article-title":"Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies","volume":"40","author":"Wang","year":"2016","journal-title":"Int. Orthop"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0220-8","article-title":"Fracture prediction, imaging and screening in osteoporosis","volume":"15","author":"Fuggle","year":"2019","journal-title":"Nat. Rev. Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4158\/EP171966","article-title":"Update on the biology of osteocalcin","volume":"23","author":"Karsenty","year":"2017","journal-title":"Endocr. Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.001","article-title":"Osteocalcin and its endocrine functions","volume":"132","author":"Mizokami","year":"2017","journal-title":"Biochem. Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/14857.6318","article-title":"Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women","volume":"9","author":"Singh","year":"2015","journal-title":"J. Clin. Diagn. Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","year":"2010","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1590\/1807-3107bor-2017.vol31.0090","article-title":"Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis","volume":"31","author":"Wang","year":"2017","journal-title":"Braz. Oral. Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2020.08.016","article-title":"Obesity-linked PPAR\u03b3 S273 phosphorylation promotes insulin resistance through growth differentiation factor 3","volume":"32","author":"Hall","year":"2020","journal-title":"Cell Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-07013-0","article-title":"Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study","volume":"35","author":"Cai","year":"2024","journal-title":"Osteoporos Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxae057","article-title":"Metformin acts on miR-181a-5p\/PAI-1 axis in stem cells providing new strategies for improving age-related osteogenic differentiation decline","volume":"42","author":"Hong","year":"2024","journal-title":"Stem Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12937","DOI":"10.1002\/kjm2.12937","article-title":"Dapagliflozin combined with metformin improves blood glucose, bone metabolism and bone mineral density in elderly patients with type 2 diabetes mellitus complicated with osteoporosis","volume":"41","author":"Zheng","year":"2025","journal-title":"Kaohsiung J. Med. Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.08.034","article-title":"Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression","volume":"375","author":"Kanazawa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01630.x","article-title":"Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin","volume":"14","author":"Ljunggren","year":"2012","journal-title":"Diabetes Obes. Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00042","article-title":"Type 2 diabetes and osteoporosis: A guide to optimal management","volume":"102","author":"Paschou","year":"2017","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e41444","DOI":"10.1097\/MD.0000000000041444","article-title":"Association of type 2 diabetes with osteoporosis and fracture risk: A systematic review and meta-analysis","volume":"104","author":"Cao","year":"2025","journal-title":"Med. (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1119915","article-title":"A bibliometric analysis based on Web of Science from 2012 to 2021: Current situation, hot spots, and global trends of medullary thyroid carcinoma","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.21037\/gs-21-799","article-title":"Bibliometric analysis of research on thyroid ultrasonography","volume":"10","author":"Su","year":"2021","journal-title":"Gland Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3791\/58494","article-title":"Comparing bibliometric analysis using PubMed, scopus, and web of science databases","volume":"152","author":"AlRyalat","year":"2019","journal-title":"J. Vis. Exp"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-9492LSF","article-title":"Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses","volume":"22","author":"Falagas","year":"2008","journal-title":"FASEB J"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1596938\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:34Z","timestamp":1749528634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1596938\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":31,"alternative-id":["10.3389\/fcdhc.2025.1596938"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2025.1596938","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1596938"}}